Lauren M. Sabella, Chief Commercial Officer at ACORDA THERAPEUTICS INC (ACOR), sold 9,310 shares at $20.66 ($192K) on 2018-12-03, disclosed to the SEC on 2018-12-06.
Seasonal sale ($192k) by Chief Commercial Officer — this insider has traded ACOR in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.20 | 1,072 | $22K | 11.3% |
| 2 | $20.66 | 4,119 | $85K | 44.4% |
| 3 | $20.66 | 4,119 | $85K | 44.4% |
| Total | $20.61 avg | 9,310 | $192K | 100% |
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |
| ACOR | SELL | 2018-06-12 | $853K | — | Filing → |